BioPharma« Terug naar discussie overzicht

1. [verwijderd] 28 maart 2006 15:05

   auteur info

   •    [verwijderd]

     Lid sinds: 01 jan 0001

     Laatste bezoek: 01 jan 0001

   •    Aanbevelingen

     Ontvangen: 0

     Gegeven: 0

   •    Aantal posts: 0

   Alweer een vogelgriep hype aandeel??? ;-) Maar proficiat voor degenen die vette winst hebben in enkele dagen!
2. [verwijderd] 29 maart 2006 11:47

   auteur info

   •    [verwijderd]

     Lid sinds: 01 jan 0001

     Laatste bezoek: 01 jan 0001

   •    Aanbevelingen

     Ontvangen: 0

     Gegeven: 0

   •    Aantal posts: 0

   quote:

   connect schreef:

   ik ken jou van versatel. ik had de aandelen en jij de negatieve berichtgeving omtrent dit telecompareltje.
   
   maar ok. ik ga met je mee in dit avontuur,heel bescheiden natuurlijk.
   
   bedankt voor de tip, moet nog top worden, gezellig en tot schrijfs.
   
   mvg ric.
   

   yellowww , jongen, bedankt voor de tip nogmaals,ik heb ze gisteren allemaal verkocht voor 44 ct, gekocht op 30 ct, hartstikke leuk, zo'n snabbeltje erbij.
   
   wel verkocht, maar wellicht wat je al zei, klein bedrijf, als ze echt iets hebben tegen een hardnekkige ziekte , dan kon dit wel eens een goudmijn worden, maar ik zat er zo klein in, dat ik dik tevreden ben . bedankt.
   
   mvg, oud versateller, ric
3. [verwijderd] 10 mei 2006 21:00

   auteur info

   •    [verwijderd]

     Lid sinds: 01 jan 0001

     Laatste bezoek: 01 jan 0001

   •    Aanbevelingen

     Ontvangen: 0

     Gegeven: 0

   •    Aantal posts: 0

   eFoodSafety.com, Inc. (EFSF) SqueezeTrigger Price is $0.35
   Wednesday May 10, 9:00 am ET
   Approximately 13.3 Million Shares Shorted since January 2005 According to BUYINS.NET Research Report
   
   SCOTTSDALE, Ariz.--(BUSINESS WIRE)--May 10, 2006--Patricia Gruden, President/CEO of eFoodSafety.com, Inc. (OTCBB:EFSF - News), announced today that BUYINS.NET, www.buyins.net, is reiterating coverage of eFoodSafety.com, Inc. after releasing the latest short sale data to May 2006. From January 2005 to May 2006 approximately 172.3 million total aggregate shares of EFSF have traded for a total dollar value of nearly $59.6 million. The total aggregate number of shares shorted in this time period is approximately 13.3 million shares. The EFSF SqueezeTrigger price of $0.35 is the volume weighted average short price of all short selling in EFSF. A short squeeze is expected to begin when shares of EFSF close above $0.35. To access SqueezeTrigger Prices ahead of potential short squeezes beginning, visit www.buyins.net.
4. [verwijderd] 19 mei 2006 17:31

   auteur info

   •    [verwijderd]

     Lid sinds: 01 jan 0001

     Laatste bezoek: 01 jan 0001

   •    Aanbevelingen

     Ontvangen: 0

     Gegeven: 0

   •    Aantal posts: 0

   eFoodSafety.com, Inc. Announces Reorders from GNC and The Vitamin Shoppe for Cinnergen Diabetes Product
   Thursday May 18, 9:30 am ET
   
   SCOTTSDALE, Ariz.--(BUSINESS WIRE)--May 18, 2006--Patricia Gruden, President/CEO of eFoodSafety.com, Inc. (OTCBB:EFSF - News), announced today that the retail acceptance for Cinnergen(TM) continues to exceed the Company's original expectations. Prior to the end of the Company's fiscal year ended April 30, 2006, it received reorders from both General Nutrition Centers, Inc. (GNC) and The Vitamin Shoppe for Cinnergen(TM), an all-natural liquid nutritional supplement designed to regulate blood sugar.
   
   ADVERTISEMENT
   GNC (http://www.gnc.com) has over 5,000 retail locations both internationally and domestically and The Vitamin Shoppe (http://www.vitaminshoppe.com) has over 260 retail locations throughout the United States and the District of Columbia.
   
   The revenue from retail sales will begin to be reflected in the Company's first-quarter results ending July 31, 2006. Customarily, there is a 60-90-day lag between product shipment and receipt of payment. The very encouraging sign is that the reorders continue to show customer acceptance of the product.
   
   Cinnergen(TM) is a patent-pending nutritional supplement with 0 calories, 0 grams of fat, 0 carbohydrates, and 0 grams of sugar. Cinnergen(TM) delivers concentrated nutrition to help the body efficiently and effectively metabolize sugar. As the body becomes more efficient with glucose metabolism, overall health is improved.
   
   "GNC and The Vitamin Shoppe are two premiere retail chains, and as the product continues to gain national exposure we feel confident that these first reorders are only the beginning of many more to follow throughout the year," stated Patricia Ross-Gruden, President and CEO of eFoodSafety.com, Inc.
   
   About Cinnergen(TM)
   
   Cinnergen(TM) (www.cinnergen.com) is a once-a-day formula made from 15 whole foods that contain no fats, carbohydrates, sugar, or calories. Cinnergen(TM) is specially formulated to promote healthy glucose metabolism and to decrease the symptoms that commonly accompany elevated blood sugar and its effects. Cinnergen(TM) delivers concentrated nutrition to help the body efficiently and effectively metabolize sugar. As a whole food complex, Cinnergen(TM) provides several key ingredients that have been proven clinically through years of research to improve digestion and utilization of sugar, which are generally deficient in a typical American diet.
   
   About eFoodSafety.com, Inc.
   
   eFoodSafety.com, Inc. is dedicated to improving food and health conditions around the world through its innovative technologies. The company's Knock-Out Technologies, Ltd. subsidiary has developed an environmentally safe sporicidal product formulated entirely of food-grade components that eradicates anthrax, and a germicidal product, Big 6 Plus -- EPA Reg. No. 82723-1 -- that kills six major bacteria: E-coli, Listeria, Pseudomonas, Salmonella, Staphylococcus, and Streptococcus, Avian Influenza, and Black Mold. The Anthrax sporicidal product has completed its final efficacy laboratory study requisite for EPA registration. In the study, it eradicated both Clostridium Sporogenes and Bacillus Subtilis with 100% efficacy on both hard and porous surfaces. The company's MedElite, Inc. subsidiary distributes clinically proven products to physicians who then prescribe the products for their patients. It is the exclusive U.S. and worldwide distributor of the Talsyn(TM)-CI/bid Scar Cream that has been clinically proven to facilitate and improve the appearance, redness and strength of scars (www.talsyn.com). The company is also is a distributor for Cinnergen(TM), a non-prescription liquid whole food nutritional supplement that promotes healthy glucose metabolism (www.cinnergen.com), and Trimmendous(TM), a weight loss formula focusing on the body's 24-hour metabolic processes. The company has recently entered into a joint venture agreement with CK41 Direct, Inc. to launch an anti-acne skin care system, with a branded name and celebrity spokesperson to be announced in the near future.
   
   Safe Harbor Forward-Looking Statements
   
   Statements contained in this release that are not strictly historical are "forward-looking" statements within the meaning of Section 27A of the Securities Act of 1933 as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. The forward-looking statements are made based on information available as of the date hereof, and the company assumes no obligation to update such forward-looking statements. Editors and investors are cautioned that such forward-looking statements invoke risk and uncertainties and the company's actual results may differ from these forward-looking statements. Such risks and uncertainties include, but are not limited to, demand for the company's products and services, our ability to continue to develop markets, general economic conditions, our ability to secure additional financing for the company and other factors that may be more fully described in reports to shareholders and periodic filings with the Securities and Exchange Commission.
   
   Contact:
   
   Redwood Consultants, LLC
   Jens Dalsgaard, 415-884-0348
5. [verwijderd] 24 mei 2006 23:36

   auteur info

   •    [verwijderd]

     Lid sinds: 01 jan 0001

     Laatste bezoek: 01 jan 0001

   •    Aanbevelingen

     Ontvangen: 0

     Gegeven: 0

   •    Aantal posts: 0

   eFoodSafety.com Inc. Launches CNN Headline News Daytime Edition Advertising Campaign for Cinnergen Diabetes Product Targeting More Than 20 Million Viewers Monthly
   Monday May 22, 10:25 am ET
   CNN Headline News Available in More Than 88 Million U.S. Households
   
   SCOTTSDALE, Ariz.--(BUSINESS WIRE)--May 22, 2006--Patricia Gruden, president/CEO of eFoodSafety.com Inc. (OTCBB:EFSF - News), announced today that Cinnergen(TM), an all-natural liquid nutritional supplement designed to regulate blood sugar, will be advertising on CNN Headline News Daytime Edition www.cnn.com/HLN/.
   
   ADVERTISEMENT
   A subsidiary of CNN (http://www.cnn.com), America's No. 1 cable news network in cumulative Nielsen ratings, CNN Headline News is available in more than 88 million U.S. households.
   
   The additional exposure the product will receive from its CNN Headline News segments will continue to introduce this product to additional consumers, thus resulting in increased retail sales of the product. This is just a continuing step in a long-term marketing strategy that is taking shape to further support our Direct Response Marketing Campaign already in place for the product.
   
   Cinnergen(TM) is a patent-pending nutritional supplement with zero calories, zero grams of fat, zero carbohydrates, and zero grams of sugar. Cinnergen(TM) delivers concentrated nutrition to help the body efficiently and effectively metabolize sugar. As the body becomes more efficient with glucose metabolism, overall health is improved.
   
   "Our 4th quarter (ended April 30, 2006) revenues will begin to show the initial results of the Cinnergen(TM) product sales, with additional revenue increases anticipated throughout the year," stated Patricia Ross-Gruden, president and CEO of eFoodSafety.com Inc.
   
   About Cinnergen(TM)
   
   Cinnergen(TM) (www.cinnergen.com) is a once-a-day formula made from 15 whole foods that contain no fats, carbohydrates, sugar, or calories. Cinnergen(TM) is specially formulated to promote healthy glucose metabolism and to decrease the symptoms that commonly accompany elevated blood sugar and its effects. Cinnergen(TM) delivers concentrated nutrition to help the body efficiently and effectively metabolize sugar. As a whole food complex, Cinnergen(TM) provides several key ingredients that have been proven clinically through years of research to improve digestion and utilization of sugar, which are generally deficient in a typical American diet.
   
   About eFoodSafety.com Inc.
   
   eFoodSafety.com Inc. is dedicated to improving food and health conditions around the world through its innovative technologies. The company's Knock-Out Technologies, Ltd. subsidiary has developed an environmentally safe sporicidal product formulated entirely of food-grade components that eradicates anthrax and a germicidal product, Big 6 Plus -- EPA Reg. No. 82723-1 -- that kills six major bacteria: E-coli, Listeria, Pseudomonas, Salmonella, Staphylococcus, and Streptococcus, Avian Influenza, and Black Mold. The Anthrax sporicidal product has completed its final efficacy laboratory study requisite for EPA registration. In the study, it eradicated both Clostridium Sporogenes and Bacillus Subtilis with 100% efficacy on both hard and porous surfaces. The company's MedElite Inc. subsidiary distributes clinically proven products to physicians who then prescribe the products for their patients. It is the exclusive U.S. and worldwide distributor of the Talsyn(TM)-CI/bid scar cream that has been clinically proven to facilitate and improve the appearance, redness and strength of scars (www.talsyn.com). The company is also is a distributor for Cinnergen(TM), a non-prescription liquid whole food nutritional supplement that promotes healthy glucose metabolism (www.cinnergen.com), and Trimmendous(TM), a weight loss formula focusing on the body's 24-hour metabolic processes. The company has recently entered into a joint venture agreement with CK41 Direct Inc. to launch an anti-acne skin care system, with a branded name and celebrity spokesperson to be announced in the near future.
6. [verwijderd] 11 juli 2006 19:31

   auteur info

   •    [verwijderd]

     Lid sinds: 01 jan 0001

     Laatste bezoek: 01 jan 0001

   •    Aanbevelingen

     Ontvangen: 0

     Gegeven: 0

   •    Aantal posts: 0

   eFoodSafety.com, Inc. to Commence Protocol Testing of Bird Flu Formula on a Wide Range of Infectious Diseases in Thailand with the Goal of Testing on Live Subjects
   Wednesday July 5, 10:30 am ET
   
   SCOTTSDALE, Ariz.--(BUSINESS WIRE)--July 5, 2006--Patricia Gruden, President/CEO of eFoodSafety.com, Inc. (OTCBB: EFSF - News), announced today the opportunity for the Company to ultimately test its Citroxin formulation on the Bird Flu virus on live subjects in Thailand after protocol testing of a wide range of infectious diseases. The Company's Citroxin formulation was hand-delivered by a Company representative to the National Center for Genetic Engineering and Biotechnology (BIOTEC), a branch of the National Science and Technology Development Agency (NSTDA) located in the greater Bangkok metropolitan area.
   
   ADVERTISEMENT
   The NSTDA was established in 1991 by the Royal Government of Thailand and officially commenced its operation in 1992. The establishment of NSTDA, unlike other public science and technology organizations in Thailand, was unique as it was aimed to "be the Agency with a high degree of autonomy and mobility unbound by the normal rules, procedures, and regulations of governmental bureaucracy" in order to "conduct, support, coordinate, and promote efforts in scientific and technological development between the public and private sectors towards maximal benefit for national development." Since its establishment, NSTDA has served as the hub where leading scientists and experts meet and work to tackle scientific and technological issues of imminent concern to both national and international communities.
   
   The significance of testing in a region that has been affected by the bird flu virus will allow for the opportunity for the Company's Citroxin formula ultimately to be tested, after background protocol testing on other infectious diseases, on live subjects.
   
   "It was recent favorable testing results of our Citroxin formulation on the bird flu in the United States that has brought about the opportunity to test abroad at one of Thailand's most prestigious agencies, the NSTDA. To have the opportunity to test the Citroxin formulation on live subjects in a region with conclusive evidence confirming the existence of the bird flu virus in animals and humans is very significant," stated Mrs. Gruden.
   
   About eFoodSafety.com, Inc.
   
   eFoodSafety.com, Inc. is dedicated to improving food and health conditions around the world through its innovative technologies. The company's Knock-Out Technologies, Ltd. subsidiary has developed an environmentally safe sporicidal product formulated entirely of food-grade components that eradicates anthrax and a germicidal product, Big 6 Plus - EPA Reg. No. 82723-1 that kills six major bacteria: E-coli, Listeria, Pseudomonas, Salmonella, Staphylococcus, and Streptococcus, Avian Influenza, and Black Mold. The sporicidal product has completed its final efficacy laboratory study requisite for EPA registration. In the study, it eradicated both Clostridium Sporogenes and Bacillus Subtilis with 100% efficacy on both hard and porous surfaces. The company's MedElite, Inc. subsidiary distributes clinically proven products to physicians who then prescribe the products for their patients. It is the exclusive U.S. and worldwide distributor of the Talsyn(TM)-CI/bid Scar Cream that has been clinically proven to facilitate and improve the appearance, redness and strength of scars (www.talsyn.com). The company is also is a distributor for Cinnergen(TM), a non-prescription liquid whole food nutritional supplement that promotes healthy glucose metabolism (www.cinnergen.com), and Trimmendous(TM), a weight loss formula focusing on the body's 24-hour metabolic processes. The company has recently entered into a joint venture agreement with CK41 Direct, Inc. to launch an anti-acne skin care system, with a branded name and celebrity spokesperson to-be-announced in the near future.
   
   Please visit the Company's website at: www.efoodsafety.com.
   
   Safe Harbor Forward-Looking Statements
   
   Statements contained in this release that are not strictly historical are "forward-looking" statements within the meaning of Section 27A of the Securities Act of 1933 as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. The forward-looking statements are made based on information available as of the date hereof, and the company assumes no obligation to update such forward-looking statements. Editors and investors are cautioned that such forward-looking statements involve risks and uncertainties and the company's actual results may differ from these forward-looking statements. Such risks and uncertainties include but are not limited to demand for the company's products and services, our ability to continue to develop markets, general economic conditions, our ability to secure additional financing for the company and other factors that may be more fully described in reports to shareholders and periodic filings with the Securities and Exchange Commission.
7. [verwijderd] 11 juli 2006 19:32

   auteur info

   •    [verwijderd]

     Lid sinds: 01 jan 0001

     Laatste bezoek: 01 jan 0001

   •    Aanbevelingen

     Ontvangen: 0

     Gegeven: 0

   •    Aantal posts: 0

   eFoodSafety.com, Inc. Subsidiary MedElite, Inc. Signs National Distribution Agreement for Talsyn Scar Cream with MedX, Inc.
   Friday July 7, 11:00 am ET
   
   SCOTTSDALE, Ariz.--(BUSINESS WIRE)--July 7, 2006--Patricia Gruden, President/CEO of eFoodSafety.com, Inc. (OTCBB:EFSF - News), announced today that the Company's wholly-owned subsidiary, MedElite, Inc., has signed a national distribution agreement with MedX, Inc, a turnkey provider of aesthetic solutions. Under the new agreement, MedX, Inc. will be the national distributor of Talsyn(TM)-CI/bid Scar Cream, a product sold only through physicians. Under the agreement, this new approach to scar management will be represented throughout the United States by sales professionals chosen and trained by MedX.
   
   ADVERTISEMENT
   "We're extremely excited to partner with MedX to manage the distribution of this revolutionary product. MedX has a proven track record of forging strong relationships with physicians of all specialties, including Plastic Surgeons, Dermatologists, Family Practitioners and OB/GYN's," said Richard Goldfarb, M.D., FACS, President/CEO of MedElite, a subsidiary of eFoodSafety.com, Inc.
   
   MedElite recently brought Talsyn(TM)-CI/bid to market as a new alternative to the silicone based gels currently available for scar healing. Talsyn(TM) is highly effective in the management of skin lacerations, abrasions, burns, surgical incisions, as well as hypertrophic and keloid scars.
   
   Talsyn's unique composition of organic ingredients includes several healing botanicals and a unique peptide which improves synthesis to hasten skin healing and regeneration. Its major active ingredient is Tamanu oil. Unlike other products used for this application, Talsyn(TM)-CI/bid leaves no residue, has a pleasant smell and does not stain clothing. As previously mentioned, Talsyn(TM) CI/bid will only be available through physicians.
   
   "MedX is honored to be granted the national distribution for Talsyn(TM)," says Mark Rubino, CEO of MedX, Inc. "Until now, there hasn't been an effective treatment for scar healing capable of improving tensile strength and appearance. We're confident that our large multi-specialty physician network and national distribution channel will embrace this new development and we are committed to introducing Talsyn(TM) to physicians across the country."
   
   MedX, Inc. is a leading provider of aesthetic solutions with over 20 years of industry experience. Their current offering includes device sales, device rental services, skin care products, consulting services, technical support, and practice building materials. MedX has created a direct selling force of industry leading professionals across the country.
   
   About eFoodSafety.com, Inc.
   
   eFoodSafety.com, Inc. is dedicated to improving food and health conditions around the world through its innovative technologies. The company's Knock-Out Technologies, Ltd. subsidiary has developed an environmentally safe sporicidal product formulated entirely of food-grade components that eradicates anthrax and a germicidal product, Big 6 Plus - EPA Reg. No. 82723-1 that kills six major bacteria: E-coli, Listeria, Pseudomonas, Salmonella, Staphylococcus, and Streptococcus, Avian Influenza, and Black Mold. The sporicidal product has completed its final efficacy laboratory study requisite for EPA registration. In the study, it eradicated both Clostridium Sporogenes and Bacillus Subtilis with 100% efficacy on both hard and porous surfaces. The company's MedElite, Inc. subsidiary distributes clinically proven products to physicians who then prescribe the products for their patients. It is the exclusive U.S. and worldwide distributor of the Talsyn(TM)-CI/bid Scar Cream that has been clinically proven to facilitate and improve the appearance, redness and strength of scars (www.talsyn.com). The company is also is a distributor for Cinnergen(TM), a non-prescription liquid whole food nutritional supplement that promotes healthy glucose metabolism (www.cinnergen.com), and Trimmendous(TM), a weight loss formula focusing on the body's 24-hour metabolic processes. The company has recently entered into a joint venture agreement with CK41 Direct, Inc. to launch an anti-acne skin care system, with a branded name and celebrity spokesperson to-be-announced in the near future.
   
   Please visit the Company's website at: www.efoodsafety.com.
8. [verwijderd] 11 juli 2006 19:32

   auteur info

   •    [verwijderd]

     Lid sinds: 01 jan 0001

     Laatste bezoek: 01 jan 0001

   •    Aanbevelingen

     Ontvangen: 0

     Gegeven: 0

   •    Aantal posts: 0

   The KonLin Letter Issues Follow-up Report on eFoodSafety.com Inc. in Its July 2006 Issue
   Tuesday July 11, 9:50 am ET
   The KonLin Letter States That 'EFSF is on the Verge of Explosive Revenue Growth'
   
   SCOTTSDALE, Ariz.--(BUSINESS WIRE)--July 11, 2006--Patricia Ross-Gruden, president and CEO of eFoodSafety.com Inc. (OTCBB: EFSF - News), announced today that The KonLin Letter issued a Follow-Up Report on eFoodSafety.com Inc. in its July 2006 issue. The KonLin Letter reiterates its "Strong Buy" recommendation of EFSF stock.
   
   According to Konrad Kuhn, editor of The KonLin Letter, Patricia Gruden has done a masterful job of repositioning the company and setting the stage for eFoodSafety.com Inc. to become a dominant player in the scar cream and diabetes markets, while bringing the company to the forefront with potential solutions in both the Lyme disease and bird flu arenas.
   
   The KonLin Letter, a 25-year-old investment advisory newsletter noted for its fundamental and technical analysis of individual stocks and market movements, does not accept compensation for its analyses of selected companies. The report includes a review of the latest developments of the company, the company's market position and potential advantages, along with fundamentals and statistics.
   
   Kuhn cited the following reasons for his July 2006 follow-up recommendation:
   
   * First quarter revenue for 2006-2007 should exceed the total revenue for all of the four quarters in Fiscal Year 2005-2006.
   * The bird flu formulation currently is in patent pending status and could be entering a multibillion-dollar market shortly. More news is anticipated on this product. Indications are that additional testing is ongoing.
   * The sales of Cinnergen(TM) from both its Direct Response Marketing Campaign and retail sales are exceeding initial expectations.
   * The Lyme's formulation is undergoing human clinical trials and initial results indicate it could become the only treatment known to treat long-term chronic Lyme disease.
   * In fiscal year 2006-2007, the anti-acne product sales are expected to commence with long-term sales estimated in the $200 million range. It is anticipated that a high-profile celebrity and brand name will be announced soon.
   
   "I've said it before and I'll say it again, never before have I seen a company with such huge upside potential in so many multibillion-dollar arenas, in my 25-year history as a newsletter writer," stated Kuhn.
   
   About KonLin Research & Analysis Corp.
   
   The KonLin Letter, www.KonLin.com, chooses low-priced stocks to analyze, with an emphasis on emerging growth and special situations poised for explosive price appreciation. The KonLin Letter has constantly been one of the leading publications on Wall Street. It has been rated one of the best-performing market letters in the nation, offering a unique service that each month recommends five low-priced selections, including a featured stock of the month. EFSF was the featured stock in the month of September 2005.
   
   About eFoodSafety.com Inc.
   
   eFoodSafety.com Inc. is dedicated to improving health conditions around the world through its innovative technologies. The company's Knock-Out Technologies Ltd. subsidiary has developed an environmentally safe sporicidal product formulated entirely of food-grade components that eradicates anthrax and a germicidal product, Big 6 Plus - EPA Reg. No. 82723-1 that kills six major bacteria: E-coli, Listeria, Pseudomonas, Salmonella, Staphylococcus, and Streptococcus, Avian Influenza, and Black Mold. The sporicidal product has completed its final efficacy laboratory study requisite for EPA registration. In the study, it eradicated both Clostridium Sporogenes and Bacillus Subtilis with 100% efficacy on both hard and porous surfaces. The company's MedElite Inc. subsidiary distributes clinically proven products to physicians who then prescribe the products for their patients. It is the exclusive U.S. and worldwide distributor of the Talsyn(TM)-CI/bid Scar Cream that has been clinically proven to facilitate and improve the appearance, redness and strength of scars (www.talsyn.com). The company is also is a distributor for Cinnergen(TM), a nonprescription liquid whole food nutritional supplement that promotes healthy glucose metabolism (www.cinnergen.com), and Trimmendous(TM), a weight loss formula focusing on the body's 24-hour metabolic processes. The company has recently entered into a joint venture agreement with CK41 Direct Inc. to launch an anti-acne skin care system, with a branded name and celebrity spokesperson to be announced in the near future.
   
   Please visit the company's Web site at www.efoodsafety.com.
9. [verwijderd] 12 juli 2006 16:35

   auteur info

   •    [verwijderd]

     Lid sinds: 01 jan 0001

     Laatste bezoek: 01 jan 0001

   •    Aanbevelingen

     Ontvangen: 0

     Gegeven: 0

   •    Aantal posts: 0

   Yelowww
   
   Ik ben geen fan van je, vanwege de vreemde postings op het Crucell-forum, maar hier moet ik je toch alle credit geven voor het vinden van dit pareltje.
   
   Dirk
10. [verwijderd] 13 juli 2006 17:54

    auteur info

    •    [verwijderd]

      Lid sinds: 01 jan 0001

      Laatste bezoek: 01 jan 0001

    •    Aanbevelingen

      Ontvangen: 0

      Gegeven: 0

    •    Aantal posts: 0

    Zie onderstaand bericht. Koers reageert altijd bijzonder scherp op berichten over de vogelgriep. Zeker als ze, zoals in dit geval, door het bedrijf zelf de ether in worden geslingerd.
    
    Konlin is dus uitermate enthousiast over efsf. Binnenkort komen de cijfers over het gebroken boekjaar. In het laatste kwartaal zouden de cijfers van cinnergen, en middel dat - natte vinger - de bloedsuikerspiegel helpt reguleren, en dat het noodzakelijke medicijngebruik voor diabetici terugdringt, in de resultaten zichtbaar moeten worden.
    
    Kaspositie is krap, dus het is tijd dat er wat geld in het laatje komt.
    Actief in meerdere miljardenmarkten - kosmetica/plastische chirurgie/diabetis/vogelgriep - en ze doen zaken met vaak landelijke ketens/groothandels die hun product aan de man brengen. Producten die, als we de verhalen mogen geloven, ook nog eens zeer effectief, en op natuurlijke basis zijn.
    
    Er staan honderd miljoen aandelen uit.
    
    Ik vind, in aansluiting op de titel, ook een spannend bedrijfje.
    
    Overigens is volgens de eigen berichtgeving de squeeze trigger price 35 cent, daar kruipen we aardig naartoe vandaag.
    
    efoodSafety.com Inc. Reports That the Bird Flu Has Spread From Human to Human
    Thursday July 13, 10:10 am ET
    
    SCOTTSDALE, Ariz.--(BUSINESS WIRE)--July 13, 2006--Patricia Ross-Gruden, president and CEO of eFoodSafety.com Inc. (OTCBB: EFSF - News), announced today that eFoodSafety.com Inc. confirms reports that the bird flu virus has spread from human to human.
    
    ADVERTISEMENT
    A report from Indonesia stated that a woman contracted the H5N1 virus, spread it to her 10-year-old son, and five other blood relatives. All but one who contracted the virus had died.
    
    On Nov. 7, 2005, Lee Jong-Wook, leader of the World Health Organization (WHO), stated, "It is only a matter of time before an avian-flu virus -- most likely H5N1 -- acquires the ability to be transmitted from human to human, sparking the outbreak of human pandemic influenza. We don't know when this will happen. But we do know that it will happen."
    
    The recent findings in Indonesia provide proof that the bird flu virus has now inevitably begun to spread between humans.
    
    In the June 24, 2006, edition of the Washington Times, United Nations Bird Flu Chief David Nabarro said this is a "vivid reminder of the need to keep a very close watch on what the virus is doing." A pandemic of bird flu would be an unprecedented disaster. Economically, the World Bank warned that a bird flu pandemic could cause global gross domestic product to drop by 2 percent -- or about $800 billion a year. It is difficult to estimate a reasonable death count, but WHO forecasts have consistently remained at 2 million to 7.4 million deaths worldwide."
    
    Ongoing testing of eFoodSafety.com Inc.'s bird flu formulation -- Citroxin -- is currently under way in this Far Eastern region. Gruden commented, "We specifically began testing in Thailand to be as close as possible to the 'hot spot' where this potential pandemic could break out."
    
    About eFoodSafety.com Inc.
    
    eFoodSafety.com Inc. is dedicated to improving health conditions around the world through its innovative technologies. The company's Knock-Out Technologies Ltd. subsidiary has developed an environmentally safe sporicidal product formulated entirely of food-grade components that eradicates anthrax and a germicidal product, Big 6 Plus - EPA Reg. No. 82723-1, that kills six major bacteria: E-coli, Listeria, Pseudomonas, Salmonella, Staphylococcus, and Streptococcus, Avian Influenza, and Black Mold. The sporicidal product has completed its final efficacy laboratory study requisite for EPA registration. In the study, it eradicated both Clostridium Sporogenes and Bacillus Subtilis with 100% efficacy on both hard and porous surfaces. The company's MedElite Inc. subsidiary distributes clinically proven products to physicians who then prescribe the products for their patients. It is the exclusive U.S. and worldwide distributor of the Talsyn(TM)-CI/bid Scar Cream that has been clinically proven to facilitate and improve the appearance, redness and strength of scars (www.talsyn.com). The company is also is a distributor for Cinnergen(TM), a nonprescription liquid whole food nutritional supplement that promotes healthy glucose metabolism (www.cinnergen.com), and Trimmendous(TM), a weight loss formula focusing on the body's 24-hour metabolic processes. The company has recently entered into a joint venture agreement with CK41 Direct Inc. to launch an anti-acne skin care system, with a branded name and celebrity spokesperson to be announced in the near future.
    
    Please visit the company's Web site at: www.efoodsafety.com.
11. [verwijderd] 13 juli 2006 17:55

    auteur info

    •    [verwijderd]

      Lid sinds: 01 jan 0001

      Laatste bezoek: 01 jan 0001

    •    Aanbevelingen

      Ontvangen: 0

      Gegeven: 0

    •    Aantal posts: 0

    Vrij typisch dat deze post als van jsw wordt aangemerkt, want ik ben jsw dus niet...
12. [verwijderd] 13 juli 2006 17:55

    auteur info

    •    [verwijderd]

      Lid sinds: 01 jan 0001

      Laatste bezoek: 01 jan 0001

    •    Aanbevelingen

      Ontvangen: 0

      Gegeven: 0

    •    Aantal posts: 0

    maar als ik nu jsw ben, wie is hij dan nu..?
13. [verwijderd] 13 juli 2006 18:05

    auteur info

    •    [verwijderd]

      Lid sinds: 01 jan 0001

      Laatste bezoek: 01 jan 0001

    •    Aanbevelingen

      Ontvangen: 0

      Gegeven: 0

    •    Aantal posts: 0

    Groene Gigant, is er een dubbele bodem in de grafiek te zien, en valt er iets meer over te zeggen?
    
    finance.yahoo.com/q/bc?s=EFSF.OB&t=5y...
14. [verwijderd] 13 juli 2006 20:31

    auteur info

    •    [verwijderd]

      Lid sinds: 01 jan 0001

      Laatste bezoek: 01 jan 0001

    •    Aanbevelingen

      Ontvangen: 0

      Gegeven: 0

    •    Aantal posts: 0

    quote:

    JSW schreef:

    Thursday July 13, 10:10 am ET
    
    SCOTTSDALE, Ariz.--(BUSINESS WIRE)--July 13, 2006--Patricia Ross-Gruden, president and CEO of eFoodSafety.com Inc. (OTCBB: EFSF - News), announced today that eFoodSafety.com Inc. confirms reports that the bird flu virus has spread from human to human.
    

    Ik heb dit niet bevestigd gezien door de officiële instanties, dus oppassen met deze berichtgeving.
    
    Dirk.
15. [verwijderd] 13 juli 2006 20:39

    auteur info

    •    [verwijderd]

      Lid sinds: 01 jan 0001

      Laatste bezoek: 01 jan 0001

    •    Aanbevelingen

      Ontvangen: 0

      Gegeven: 0

    •    Aantal posts: 0

    staat op uitbreken?
    
    zullen we afspreken dat ie boven de 50 pas uitbreekt anders?
    
    lekkere chart:
    
    chart.finance.yahoo.com/c/2y/e/efsf.ob
    
    schiet niet op, rommel
16. [verwijderd] 16 oktober 2006 22:16

    auteur info

    •    [verwijderd]

      Lid sinds: 01 jan 0001

      Laatste bezoek: 01 jan 0001

    •    Aanbevelingen

      Ontvangen: 0

      Gegeven: 0

    •    Aantal posts: 0

    eFoodSafety.com Inc. Reports Completion of Clinical Trials on Talsyn-CI/bid Scar Cream
    Thursday August 24, 10:10 am ET
    Overwhelmingly Favorable Results in a Comparative Analysis-Cohort Study with Talsyn-CI/bid Scar Cream vs. Silicone-Based Scar Cream Products
    
    SCOTTSDALE, Ariz.--(BUSINESS WIRE)--Aug. 24, 2006--Richard M. Goldfarb, M.D., FACS, president and CEO of MedElite Inc., a wholly owned subsidiary of eFoodsafety.com Inc. (OTCBB:EFSF - News), announced today that after completion of a 12-week study, Talsyn CI/bid statistically and significantly outperformed the silicone-based scar products in all categories including aesthetic appearance. Patient preference for Talsyn CI/bid was 94%.
    
    ADVERTISEMENT
    The study design used each product on the same patient over different areas of a scar. This eliminated any bias in the individual ability to heal.
    
    "The completion of this study enables us to provide documentation that will lead to a high level of confidence when recommending the use of Talysn CI/bid to physicians," stated Dr. Goldfarb.
    
    "As physicians, we rely heavily on scientific data in order to make a determination of the effectiveness of products we suggest to our patients. This study will provide our marketing team the convincing documentation to present to physicians and should boost the sale of Talysn CI/bid to the physician market," added Dr. Goldfarb.
    
    "This is another step in building this product into one of the premier health care products under the eFoodSafety umbrella," stated Patricia Gruden, president and CEO of eFoodSafety.com Inc.
    
    Please visit the company's Web site at: www.efoodsafety.com.
    
    
17. [verwijderd] 16 oktober 2006 22:17

    auteur info

    •    [verwijderd]

      Lid sinds: 01 jan 0001

      Laatste bezoek: 01 jan 0001

    •    Aanbevelingen

      Ontvangen: 0

      Gegeven: 0

    •    Aantal posts: 0

    eFoodSafety.com Inc. Reports Record First Quarter Revenues
    Monday September 18, 10:15 am ET
    Company's First Quarter Fiscal 2007 Revenue Nearly Exceeds Total Fiscal Year Ended April 30, 2006 Revenues
    
    SCOTTSDALE, Ariz.--(BUSINESS WIRE)--Sept. 18, 2006--eFoodSafety.com Inc. (OTCBB: EFSF - News), dedicated to improving health conditions around the world through innovative products and technologies, announced today that the company reported record revenues in excess of $500,000 for the first quarter ended July 31, 2006, in its Form 10-QSB filed with the Securities and Exchange Commission. These record revenues nearly exceeded the company's revenues for the entire prior fiscal year ended April 30, 2006.
    
    ADVERTISEMENT
    Patricia Gruden, eFoodSafety CEO, stated, "We are extremely pleased to announce record company revenues in the quarter. I believe we have now reached an inflection point and that these tangible results clearly demonstrate that we are now expeditiously moving eFoodSafety and many of its products and technologies from the developmental stage to the marketing stage. Importantly, we have also reduced our debt while maintaining a strong financial position which we anticipate will provide us with sufficient capital to operate all divisions through our next fiscal year."
    
    Gruden further commented, "The strategic initiatives we began in September 2005 when I became president of the company have now clearly begun to show positive results. I am cautiously optimistic that these initial results are only the beginning of many significant strategic steps that will continue to materialize in upcoming months. The company and its divisions, MedElite Inc. and Knock Out Technologies, Ltd., are committed to the continuous development and marketing of its products, including those already announced and new products in the pipeline. We anticipate providing our shareholders with further information on these favorable developments in the near-term as we remain focused on building shareholder value."
    
    Please visit the company's Web site at: www.efoodsafety.com.
    
    
18. [verwijderd] 16 oktober 2006 22:17

    auteur info

    •    [verwijderd]

      Lid sinds: 01 jan 0001

      Laatste bezoek: 01 jan 0001

    •    Aanbevelingen

      Ontvangen: 0

      Gegeven: 0

    •    Aantal posts: 0

    eFoodSafety.com, Inc. Wholly-Owned Subsidiary MedElite, Inc. Acquires Full Talsyn Product Line
    Monday September 25, 10:10 am ET
    MedElite to Acquire Patent, Trademarks and Control Manufacturing and Distribution
    
    SCOTTSDALE, Ariz.--(BUSINESS WIRE)--eFoodSafety.com, Inc. (OTCBB: EFSF - News), dedicated to improving health conditions around the world through innovative products and technologies, announced today that its wholly-owned subsidiary, MedElite, Inc., has acquired all the trademarks, patents, and manufacturing and distribution rights for the Talsyn(TM)-CI/bid scar cream and seven other products in the Talsyn(TM) line.
    
    ADVERTISEMENT
    click here
    MedElite President Dr. Richard Goldfarb stated, "After nearly one year of market testing, planning and establishing ourselves with a premiere distributor such as MedX, Inc., we are now ready to fully launch the Talsyn(TM)-CI/bid scar cream worldwide. Acquiring the manufacturing rights to the Talsyn(TM)-CI/bid scar cream and the other products in the Talsyn(TM) line was a major step towards expanding the products' worldwide distribution. Importantly, acquiring the manufacturing rights facilitates stronger earnings leverage by potentially increasing profit margins while still allowing us the opportunity to control and meet the demand and fulfillment projections of MedX, Inc."
    
    Dr. Goldfarb further stated, "Physicians' initial reactions to the Talsyn(TM)-CI/bid scar cream have been overwhelmingly positive. Not only have the physicians been supportive of the products' effectiveness but the results have further been solidified by our own clinical study. Our most compelling competitive advantage is that the product can be applied anywhere and does not stain clothes or leave a stick residue like the competitors' silicone-based products."
    
    Please visit the Company's website at: www.efoodsafety.com.
    
19. [verwijderd] 16 oktober 2006 22:23

    auteur info

    •    [verwijderd]

      Lid sinds: 01 jan 0001

      Laatste bezoek: 01 jan 0001

    •    Aanbevelingen

      Ontvangen: 0

      Gegeven: 0

    •    Aantal posts: 0

    Webcast.
    De man doet niet veel meer dan herhalen wat ook al in de persberichten is vermeld. Geen data, wel heel erg enthousiast over de (nabije) toekomst.
    
    Webcast Alert: eFoodSafety.com, Inc. Announces Its eFoodSafety.com Small Cap IIF Webcast
    Monday October 2, 9:35 am ET
    
    SCOTTSDALE, Ariz.--(BUSINESS WIRE)--eFoodSafety.com, Inc. (OTCBB:EFSF - News) announces the following Webcast:
    
    What: eFoodSafety.com, Inc. eFoodSafety.com Small Cap IIF Webcast
    
    When: October 3, 2006 @ 03:00 PM Eastern
    
    Where: www.vcall.com/EventPage.asp?ID=109345
    
    Zijn we weer even bij...
20. [verwijderd] 7 november 2006 20:22

    auteur info

    •    [verwijderd]

      Lid sinds: 01 jan 0001

      Laatste bezoek: 01 jan 0001

    •    Aanbevelingen

      Ontvangen: 0

      Gegeven: 0

    •    Aantal posts: 0

    eFoodSafety.com, Inc. Reports Bird Flu Testing Underway in Thailand
    Thursday November 2, 9:30 am ET
    Company expects this testing process to reaffirm already favorable results it has received on the U.S. testing of Citroxin on the H5N1 Bird Flu virus
    
    SCOTTSDALE, Ariz.--(BUSINESS WIRE)--eFoodSafety.com, Inc. (OTCBB: EFSF - News), dedicated to improving health conditions around the world through innovative products and technologies, today announced that testing of the Company's Citroxin product on the Bird Flu using live tissue samples is currently underway.
    
    ADVERTISEMENT
    The testing is being conducted by Innova Biotechnology Co. Ltd., which is one of Thailand's largest private biotechnology company's, specializing in advanced research, development and manufacturing of rapid test immunodiagnostic test devices for health care applications. The company is a joint venture enterprise between leading private business and scientists, and the National Science and Technology Development Agency (NSTDA) and is supported be the National Center for Genetic Engineering and Biotechnology (BIOTEC) and the National Innovation Agency.
    
    The Company expects this testing process to reaffirm the already favorable results it has received on the U.S. testing of Citroxin on the Avian Influenza A Flu virus. After the Company has received test results confirming continued success, live subject testing can begin on the product immediately.
    
    The slight delays the Company experienced in getting this testing underway dealt with the clear definition of testing protocol issues due to the major concern of Bird Flu in this region and the world as a whole. The significance of establishing a defined protocol procedure allows the company to begin live subject testing without further delays.
    
    Patricia Gruden, President and CEO of eFoodSafety.com, Inc. stated "We are pleased to have commenced live tissue testing at the respected National Center for Genetic Engineering and Biotechnology. Over the several past months, we have methodically progressed to this point with a keen understanding that the implications of successful live tissue testing of Citroxin could be substantial. It is with this that we have diligently followed the defined protocol to ensure accuracy relating to the products effectiveness on the Bird Flu Virus."
    
    Gruden further commented, "Based on previous U.S. testing, we remain cautiously optimistic that our Citroxin product will have a material impact in immobilizing this potential pandemic. It remains our intention to immediately communicate these results to our shareholders upon receipt of them."
    
    About eFoodSafety.com, Inc.
    
    eFoodSafety.com, Inc. is dedicated to improving health conditions around the world through its innovative technologies. The company's Knock-Out Technologies, Ltd. subsidiary has developed an environmentally safe sporicidal product formulated entirely of food-grade components that eradicates anthrax and a germicidal product, Citroxin (formerly named Big Six Plus) - EPA Reg. No. 82723-1 that kills six major bacteria: E-coli, Listeria, Pseudomonas, Salmonella, Staphylococcus, and Streptococcus, Avian Influenza, Black Mold. The sporicidal product has completed its final efficacy laboratory study requisite for EPA registration. In the study, it eradicated both Clostridium Sporogenes and Bacillus Subtilis with 100% efficacy on both hard and porous surfaces. The company's MedElite, Inc. subsidiary distributes clinically proven products to physicians who then prescribe the products for their patients. It recently became the owner of the Talsyn(TM)-CI/bid Scar Cream, that has been clinically proven to facilitate and improve the appearance, redness and strength of scars (www.talsyn.com), as well as seven (7) other products in the Talsyn(TM) line. The company is also is a distributor for Cinnergen(TM), a non-prescription liquid whole food nutritional supplement that promotes healthy glucose metabolism (www.cinnergen.com), and Trimmendous(TM), a weight loss formula focusing on the body's 24-hour metabolic processes. The company has recently entered into a joint venture agreement with CK41 Direct, Inc. to launch an anti-acne skin care system, with a branded name and celebrity spokesperson to-be-announced in the near future.
    
    Please visit the Company's website at: www.efoodsafety.com.